Involvement of L-type calcium channel and SERCA2a in myocardial dysfunction induced by obesity

André Soares Leopoldo1, Ana Paula Lima-Leopoldo, Mário Mateus Sugizaki

  • 1Department of Clinical and Cardiology, School of Medicine, UNESP- State University Júlio Mesquita Filho, Botucatu, São Paulo, Brazil. andresoaresleopoldo@gmail.com

Insights

Obesity impairs heart function by affecting calcium handling. Obese rats showed impaired L-type calcium channel activity, contributing to cardiac dysfunction without altering SERCA2a levels.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Molecular Biology

Background:

  • Obesity is linked to impaired myocardial performance.
  • Mechanisms of cardiac dysfunction in obesity, particularly calcium handling, are not fully understood.
  • L-type calcium channels and SERCA2a are potential contributors to obesity-induced cardiac issues.

Purpose of the Study:

  • To investigate if myocardial dysfunction in obese rats is associated with altered activity or expression of L-type calcium channels and SERCA2a.
  • To explore the role of calcium handling proteins in obesity-related cardiac dysfunction.

Main Methods:

  • Obesity was induced in Wistar rats using high-fat diets for 15 weeks.
  • Myocardial function was assessed in isolated papillary muscles.
  • L-type calcium channel and SERCA2a activity were measured using specific blockers; protein levels were analyzed via Western blot.

Main Results:

  • Obese rats exhibited increased body fat, adiposity, and comorbidities.
  • Myocardial responsiveness to stimuli and increased extracellular calcium was compromised in obese rats.
  • Diltiazem showed greater inhibition of tension in obese rats, indicating impaired L-type calcium channel activity, with no significant changes in SERCA2a activity or expression.

Conclusions:

  • Obesity-induced myocardial dysfunction is linked to impaired L-type calcium channel activity.
  • SERCA2a expression and function, as well as L-type calcium channel protein levels, remained unchanged.
  • Calcium handling, specifically L-type calcium channel function, plays a role in cardiac dysfunction associated with obesity.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...